InMode Ltd. Stock News

'Mad Money' host Jim Cramer makes the case for medical device companies in a post-COVID market.

Medical device maker InMode's aesthetic products have been in high demand. This has led to some terrific growth numbers for the business.

YOKNEAM, Israel , May 17, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following i

Teladoc has recently put the focus on the path to profitability. InMode has delivered gains in earnings over time.

Investing in growth stocks can be far less risky if you make smaller, more frequent purchases of your favorite companies. Axsome Therapeutics is a commercial-stage drugmaker that recently launched a n

InMode is a medical device maker gaining a share of the rapidly growing market for minimally invasive cosmetic procedures. Despite a tough period for making comparisons, InMode reported first-quarter

InMode is a leading provider of innovative, energy-based, and minimally invasive aesthetic and medical treatment solutions. The company has seen explosive growth on both the top line and bottom line

The medical aesthetics specialist notched solid revenue and profitability beats in its first quarter. There was a big catch to its performance, however.

InMode beat first-quarter expectations Tuesday, but shares of the company tumbled on its lackluster sales and earnings outlook. The post InMode, A Top 1% Stock, Crumbles On Lackluster Sales, Earnings

Here's an options trade to play the upside in INMD stock with unlimited profit potential and limited downside risk. New to trading?

Unlimited profit potential and limited risk makes this option strategy attractive. The post This Option Strategy Makes INMD Stock More Attractive appeared first on Investor's Business Daily.

Vertex Pharmaceuticals is a leader in its field, bringing in billions of dollars in annual earnings. Teladoc Health has steadily grown revenue, and telemedicine visits, by at least double-digit percen

Growth stocks can be unpredictable, but dollar-cost averaging is an easy way for everyday investors to avoid putting too many chips on a stock just before it tanks. Amazon and Shopify are two magnific

The consensus price target hints at a 33.7% upside potential for InMode (INMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r

Shares of InMode Ltd. INMD climbed 1.1% in premarket trading Wednesday, after the Israel-based medical technologies company provided upbeat earnings guidance.